Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Judith Shlay

Concepts (244)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sexually Transmitted Diseases
11
2020
166
2.250
Why?
Text Messaging
7
2022
184
2.150
Why?
School Health Services
7
2015
224
2.090
Why?
Sexual Health
6
2022
66
2.060
Why?
Immunization Programs
6
2015
194
1.940
Why?
Pregnancy in Adolescence
4
2017
84
1.450
Why?
Safety-net Providers
2
2020
131
1.110
Why?
Opioid-Related Disorders
3
2022
602
1.090
Why?
Sexual Behavior
10
2022
492
0.980
Why?
Influenza Vaccines
4
2015
532
0.980
Why?
Condoms
5
2016
101
0.970
Why?
Stereotyping
1
2026
47
0.930
Why?
Health Promotion
4
2026
777
0.920
Why?
Reimbursement Mechanisms
3
2015
80
0.900
Why?
Colorado
16
2026
4579
0.800
Why?
Social Stigma
1
2026
172
0.790
Why?
Insurance, Health, Reimbursement
2
2014
97
0.780
Why?
Ambulatory Care Facilities
5
2013
266
0.750
Why?
Language
1
2026
323
0.750
Why?
Pregnancy, Unwanted
3
2009
15
0.710
Why?
Electronic Health Records
3
2026
1177
0.690
Why?
Attitude to Health
2
2014
436
0.660
Why?
Body Composition
7
2010
708
0.660
Why?
Analgesics, Opioid
4
2022
1145
0.650
Why?
Family Planning Services
2
2013
94
0.640
Why?
Contraception Behavior
2
2016
108
0.620
Why?
Substance-Related Disorders
2
2026
1094
0.610
Why?
HIV Infections
13
2026
3158
0.600
Why?
Contraception
5
2022
170
0.580
Why?
Papillomavirus Infections
6
2013
346
0.570
Why?
Patient Participation
2
2019
433
0.540
Why?
Influenza, Human
2
2014
617
0.540
Why?
Parental Consent
2
2014
25
0.520
Why?
Reverse Transcriptase Inhibitors
2
2008
87
0.520
Why?
Anti-HIV Agents
4
2009
890
0.500
Why?
Opiate Substitution Treatment
1
2019
187
0.490
Why?
Sex Education
1
2016
34
0.480
Why?
Adolescent
26
2026
22507
0.480
Why?
Papanicolaou Test
4
2013
35
0.470
Why?
Vaginal Smears
4
2013
55
0.460
Why?
Parents
2
2014
1404
0.450
Why?
Adolescent Health Services
1
2015
75
0.430
Why?
Minority Health
1
2014
18
0.410
Why?
Female
48
2026
78605
0.410
Why?
Financing, Government
1
2014
53
0.410
Why?
Social Values
1
2014
42
0.400
Why?
Patient Protection and Affordable Care Act
1
2014
103
0.400
Why?
Adult
34
2026
40627
0.380
Why?
Delivery of Health Care
3
2022
947
0.380
Why?
Pregnancy
15
2026
7208
0.370
Why?
Health Care Costs
2
2014
427
0.360
Why?
Humans
53
2026
145305
0.350
Why?
Geographic Information Systems
1
2011
46
0.340
Why?
Male
31
2026
72628
0.340
Why?
Tumor Virus Infections
1
2011
49
0.340
Why?
Stavudine
2
2008
6
0.330
Why?
Dideoxynucleosides
2
2008
24
0.330
Why?
Lamivudine
2
2008
65
0.320
Why?
Subcutaneous Fat
3
2010
78
0.300
Why?
Social Support
1
2014
652
0.300
Why?
Vaccines
1
2014
390
0.290
Why?
Anti-Retroviral Agents
4
2013
250
0.280
Why?
Public Health
1
2013
566
0.270
Why?
Zidovudine
1
2008
77
0.270
Why?
Vaccination
3
2013
1428
0.270
Why?
Insurance, Health
3
2015
307
0.250
Why?
HIV Protease Inhibitors
1
2007
69
0.250
Why?
Costs and Cost Analysis
2
2020
220
0.250
Why?
Health Status
1
2011
837
0.240
Why?
Indians, North American
1
2011
610
0.230
Why?
Program Evaluation
4
2026
949
0.230
Why?
Patient Compliance
1
2009
589
0.220
Why?
Primary Health Care
2
2014
1737
0.220
Why?
Papillomavirus Vaccines
3
2013
298
0.220
Why?
Respiratory Syncytial Virus, Human
1
2026
81
0.220
Why?
Natural Language Processing
1
2026
103
0.220
Why?
Antiretroviral Therapy, Highly Active
5
2010
278
0.220
Why?
Focus Groups
3
2026
579
0.210
Why?
Middle Aged
20
2019
36021
0.210
Why?
Risk Assessment
3
2013
3686
0.210
Why?
Respiratory Syncytial Virus Infections
1
2026
136
0.210
Why?
Pregnancy Complications, Infectious
2
2026
429
0.210
Why?
Attitude of Health Personnel
1
2012
1196
0.210
Why?
Community-Institutional Relations
2
2015
101
0.210
Why?
Health Knowledge, Attitudes, Practice
3
2026
1420
0.200
Why?
Physicians
1
2012
950
0.200
Why?
Diagnostic Errors
1
2005
177
0.200
Why?
HIV-1
4
2011
897
0.190
Why?
Pelvic Inflammatory Disease
1
2022
12
0.180
Why?
Follow-Up Studies
6
2017
5431
0.180
Why?
Intrauterine Devices
1
2022
29
0.180
Why?
Reproductive Health
1
2022
91
0.180
Why?
Long-Acting Reversible Contraception
1
2022
34
0.170
Why?
Human papillomavirus 16
2
2011
27
0.170
Why?
United States
9
2020
16051
0.170
Why?
Patient Acceptance of Health Care
3
2014
887
0.160
Why?
Heroin
1
2020
29
0.150
Why?
Allied Health Personnel
1
2020
55
0.150
Why?
Cardiovascular Diseases
1
2011
2182
0.150
Why?
Incidence
4
2013
2892
0.140
Why?
Prevalence
5
2013
2838
0.140
Why?
Multivariate Analysis
4
2009
1540
0.140
Why?
Drug Prescriptions
1
2020
286
0.140
Why?
HIV-Associated Lipodystrophy Syndrome
2
2010
11
0.130
Why?
Lipids
3
2009
712
0.130
Why?
Inpatients
1
2022
551
0.130
Why?
Uterine Cervical Neoplasms
2
2013
270
0.130
Why?
Young Adult
6
2026
14163
0.130
Why?
Cost-Benefit Analysis
2
2013
639
0.120
Why?
Adipose Tissue
4
2010
653
0.120
Why?
Child
5
2019
22712
0.120
Why?
Reminder Systems
1
2017
141
0.120
Why?
Medicaid
1
2020
466
0.120
Why?
Organizational Case Studies
1
2015
69
0.110
Why?
Drug Overdose
1
2020
370
0.110
Why?
Women's Health
2
2009
310
0.110
Why?
Inflammation
1
2026
2881
0.110
Why?
Direct Service Costs
1
2014
8
0.100
Why?
Health Plan Implementation
1
2015
141
0.100
Why?
Immunization Schedule
1
2015
188
0.100
Why?
Machine Learning
1
2020
589
0.100
Why?
Cervix Uteri
2
2011
51
0.100
Why?
National Health Programs
1
2013
23
0.100
Why?
AIDS Dementia Complex
1
2013
52
0.100
Why?
Sex Counseling
2
2003
4
0.100
Why?
Models, Immunological
1
2013
100
0.090
Why?
Research Design
1
2019
1137
0.090
Why?
Cross-Sectional Studies
6
2013
5883
0.090
Why?
Emergency Medical Services
1
2020
697
0.090
Why?
Clinical Trials as Topic
1
2017
1063
0.090
Why?
Health Services Needs and Demand
1
2014
281
0.090
Why?
Uterine Cervical Dysplasia
2
2011
27
0.090
Why?
Mass Screening
2
2013
1357
0.090
Why?
Time Factors
4
2013
7186
0.090
Why?
Medroxyprogesterone Acetate
1
2011
37
0.090
Why?
Human papillomavirus 18
1
2011
12
0.090
Why?
Schools
1
2014
453
0.080
Why?
Contraceptive Agents, Female
1
2011
80
0.080
Why?
Protease Inhibitors
1
2011
102
0.080
Why?
Self Efficacy
1
2014
414
0.080
Why?
Chi-Square Distribution
1
2011
529
0.080
Why?
Hospitalization
1
2020
2443
0.080
Why?
Urban Population
2
2004
495
0.080
Why?
Long QT Syndrome
1
2011
69
0.080
Why?
Regression Analysis
2
2009
1003
0.080
Why?
Health Education
1
2013
358
0.070
Why?
Risk-Taking
2
2002
328
0.070
Why?
Learning
1
2013
452
0.070
Why?
Life Style
1
2011
483
0.070
Why?
Ambulatory Care
1
2013
603
0.070
Why?
Neuropsychological Tests
1
2013
1138
0.070
Why?
Pilot Projects
1
2014
1894
0.070
Why?
Virology
1
2008
36
0.070
Why?
Cohort Studies
4
2008
5982
0.070
Why?
Odds Ratio
1
2009
1077
0.060
Why?
Osteoporosis
1
2009
236
0.060
Why?
Aged
6
2011
26001
0.060
Why?
Bone Density
1
2009
482
0.060
Why?
Risk Factors
5
2011
10816
0.060
Why?
Didanosine
1
2005
13
0.060
Why?
Practice Guidelines as Topic
1
2013
1568
0.060
Why?
Socioeconomic Factors
1
2009
1327
0.050
Why?
Genital Diseases, Female
1
2005
31
0.050
Why?
Vaginosis, Bacterial
1
2004
10
0.050
Why?
Prospective Studies
2
2009
8011
0.050
Why?
Community-Based Participatory Research
1
2026
166
0.050
Why?
Urban Health Services
1
2004
71
0.050
Why?
Abortion, Therapeutic
1
2003
3
0.050
Why?
Spermatocidal Agents
1
2003
7
0.050
Why?
CD4 Lymphocyte Count
3
2010
278
0.050
Why?
Fetal Blood
1
2026
342
0.050
Why?
Pregnancy Rate
1
2003
69
0.050
Why?
Catheters, Indwelling
1
2003
97
0.050
Why?
Killer Cells, Natural
1
2026
469
0.050
Why?
Hysterectomy
1
2003
138
0.050
Why?
Randomized Controlled Trials as Topic
2
2015
1747
0.050
Why?
Dendritic Cells
1
2026
499
0.050
Why?
Community Health Centers
1
2002
59
0.040
Why?
Program Development
2
2015
370
0.040
Why?
Longitudinal Studies
1
2009
2959
0.040
Why?
Contraceptive Agents
1
2022
65
0.040
Why?
Risk
1
2004
912
0.040
Why?
Postoperative Care
1
2003
290
0.040
Why?
Forecasting
1
2002
392
0.040
Why?
Insulin Resistance
2
2009
1243
0.040
Why?
Papillomaviridae
2
2013
115
0.040
Why?
Blood Glucose
2
2009
2333
0.040
Why?
Counseling
1
2003
409
0.040
Why?
Sensitivity and Specificity
1
2005
1992
0.040
Why?
Immunity, Innate
1
2026
846
0.040
Why?
Child, Preschool
1
2014
11863
0.040
Why?
Logistic Models
1
2004
2119
0.040
Why?
Absorptiometry, Photon
2
2010
276
0.040
Why?
Proportional Hazards Models
1
2002
1328
0.030
Why?
Insulin
2
2009
2507
0.030
Why?
Referral and Consultation
1
2003
853
0.030
Why?
Predictive Value of Tests
1
2002
2118
0.030
Why?
Retrospective Studies
3
2022
17149
0.030
Why?
Viral Load
2
2011
527
0.030
Why?
Electric Impedance
2
2007
111
0.030
Why?
Automation
1
2015
102
0.030
Why?
Motivation
1
2020
612
0.030
Why?
Cell Phone
1
2015
82
0.030
Why?
Infant, Newborn
1
2026
6456
0.030
Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
2013
13
0.020
Why?
Epidemiological Monitoring
1
2013
69
0.020
Why?
Data Collection
1
2015
635
0.020
Why?
Coitus
1
2011
23
0.020
Why?
Infant
1
2026
10101
0.020
Why?
Sentinel Surveillance
1
2011
46
0.020
Why?
Sex Factors
2
2008
2115
0.020
Why?
Electrocardiography, Ambulatory
1
2011
64
0.020
Why?
Subcutaneous Fat, Abdominal
1
2010
15
0.020
Why?
Needs Assessment
1
2013
406
0.020
Why?
Radionuclide Imaging
1
2010
113
0.020
Why?
Sexual Partners
1
2011
192
0.020
Why?
Health Behavior
1
2015
789
0.020
Why?
Hip Joint
1
2009
172
0.020
Why?
Adolescent Behavior
1
2013
501
0.020
Why?
Lumbar Vertebrae
1
2009
252
0.020
Why?
Drug Administration Schedule
1
2009
783
0.020
Why?
Chemical and Drug Induced Liver Injury
1
2008
139
0.020
Why?
Dose-Response Relationship, Drug
1
2011
2032
0.020
Why?
Gastrointestinal Diseases
1
2008
216
0.010
Why?
Anthropometry
1
2005
200
0.010
Why?
Polymerase Chain Reaction
1
2008
1054
0.010
Why?
Liver Diseases
1
2008
305
0.010
Why?
Metronidazole
1
2004
20
0.010
Why?
Prognosis
1
2013
4310
0.010
Why?
Treatment Outcome
2
2011
11731
0.010
Why?
Verbal Behavior
1
2004
43
0.010
Why?
Fractures, Bone
1
2009
416
0.010
Why?
Infectious Disease Transmission, Vertical
1
2004
193
0.010
Why?
Device Removal
1
2003
143
0.010
Why?
Anti-Infective Agents
1
2004
242
0.010
Why?
RNA, Viral
1
2005
688
0.010
Why?
Recurrence
1
2004
1138
0.010
Why?
Evidence-Based Medicine
1
2004
737
0.010
Why?
Smoking
1
2007
1472
0.010
Why?
Surveys and Questionnaires
1
2013
6079
0.010
Why?
Age Factors
1
2007
3339
0.010
Why?
Tomography, X-Ray Computed
1
2009
2745
0.010
Why?
Body Mass Index
1
2007
2439
0.010
Why?
Pain
1
2003
784
0.010
Why?
Shlay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)